These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14757667)

  • 1. Use of MRI in the identification and treatment of early ischemic stroke lesions.
    O'Rourke F; Akhtar N; Emery D; Shuaib A
    CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
    [No Abstract]   [Full Text] [Related]  

  • 2. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility and logistics of MRI before thrombolytic treatment.
    Sølling C; Ashkanian M; Hjort N; Gyldensted C; Andersen G; Østergaard L
    Acta Neurol Scand; 2009 Sep; 120(3):143-9. PubMed ID: 19133866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
    Finnigan SP; Rose SE; Chalk JB
    Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging helps identify who benefits from stroke intervention.
    Yuh WT; Taoka T; Ueda T; Chaloupka JC
    Diagn Imaging (San Franc); 1999 Dec; 21(12):77-82. PubMed ID: 10724845
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients.
    Salat D; Delgado P; Alonso S; Ribó M; Santamarina E; Quintana M; Alvarez-Sabín J; Montaner J
    Eur Neurol; 2011; 65(2):82-7. PubMed ID: 21346358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful intravenous thrombolysis for acute stroke in a child.
    Ortiz GA; Koch S; Wallace DM; Lopez-Alberola R
    J Child Neurol; 2007 Jun; 22(6):749-52. PubMed ID: 17641263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ischemic stroke: Not a moment to lose.
    Miller J; Mink J
    Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
    Hsieh HC; Chen CH
    Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail?
    Levine SR
    J Neurol Sci; 2004 Oct; 225(1-2):1-2. PubMed ID: 15465078
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.